Matthew Porteus

Matthew Porteus

Corporate Officer/Principal bij
Stanford School of Medicine
61 jaar
Consumer Services
Health Technology

Profiel

Matthew Porteus is the founder of CRISPR Therapeutics AG, founded in 2013.
Dr. Porteus was the founder of Graphite Bio, Inc., founded in 2017, and served as Director.
Dr. Porteus is also the founder of Kamau Therapeutics, Inc...
Dr. Porteus is a Professor at Stanford University.
Dr. Porteus is an Associate Professor at Stanford School of Medicine since 2010.
Dr. Porteus was an Assistant Professor at The University of Texas Southwestern Medical Center from 2003 to 2010.
Dr. Porteus completed undergraduate studies at Harvard University.
Dr. Porteus earned a doctorate from Stanford University.

Actieve functies van Matthew Porteus

BedrijvenFunctieBegin
Corporate Officer/Principal 01-10-2010
Corporate Officer/Principal -

Eerdere bekende functies van Matthew Porteus

BedrijvenFunctieEinde
Corporate Officer/Principal 01-08-2010
LENZ THERAPEUTICS, INC. Oprichter -
CRISPR THERAPEUTICS AG Oprichter -
Ervaring van Matthew Porteus in detail bekijken

Opleiding van Matthew Porteus

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

95

Eerstegraads connecties

6

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit6

Consumer Services

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

  1. Beurs
  2. Insiders
  3. Matthew Porteus